The Gavi vaccine alliance has reached an agreement with Danish pharmaceutical company Bavarian Nordic to obtain 500,000 doses of mpox vaccine for African countries dealing with an outbreak of the virus.

The global vaccine group Gavi has ordered 500,000 mpox vaccine doses from the German-Danish company Bavarian Nordic. The UN Children's Fund is to deliver these to affected countries in Africa later this year,

The Gavi vaccine alliance announced Wednesday a deal with Danish drugmaker Bavarian Nordic to secure 500,000 jabs against mpox for use in African countries facing an epidemic of the virus. The announcement came after the World Health Organization last week ...

Gavi, the Vaccine Alliance, is purchasing 500,000 mpox vaccines from Bavarian Nordic A/S for African countries hardest-hit by the lethal outbreak of the disease that causes lesions that can also result in blindness and disfigurement.

Gavi has committed to purchasing 500,000 doses of Bavarian Nordic's mpox vaccine to address the ongoing outbreak in Africa, particularly in the Democratic Republic of Congo. The initiative involves a $50 million spend,

Bavarian Nordic A/S (OMX: BAVA) and Gavi, the Vaccine Alliance, today announced an advance purchase agreement (APA) to

The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak.

The approval of Danish vaccine maker Bavarian Nordic’s jab means that donors, such as UNICEF and the vaccines alliance Gavi, can buy doses and send them to Africa, where an outbreak centred in the Democratic Republic of the Congo has led to thousands of cases.

Gavi is using as much as $50 million from its new emergency response fund, with that cash being used to buy the vaccines as well as pay for all the related costs including delivery and administration.

The UK government has ordered more than 150,000 doses of Bavarian Nordic's mpox vaccine to boost its preparedness against a new form of the virus currently spreading in African countries.